Budesonide Alternatives Compared
Budesonide | Entyvio | Zeposia |
|
---|
Budesonide | Entyvio (vedolizumab) | Zeposia (ozanimod) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Crohn's Disease, Asthma - Maintenance, Crohn's Disease - Active, Autoimmune Hepatitis, Inflammatory Bowel Disease, Crohn's Disease - Maintenance, Primary Immunoglobulin A Nephropathy... View more |
Prescription only
Entyvio is an integrin receptor antagonist that may be used to reduce inflammation associated with moderate to severe ulcerative colitis or Crohn's disease. It targets the gut specifically instead of... View more |
Prescription only
Zeposia is an S1P receptor modulator that may be used to treat relapsing forms of multiple sclerosis or ulcerative colitis in adults. It requires a 7-day titration period and reduces lymphocyte... View more |
Related suggestions Ulcerative Colitis
|
|||||||||||||||||||||||
More about Budesonide | More about Entyvio (vedolizumab) | More about Zeposia (ozanimod) | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
No lower-cost generic available |
No lower-cost generic available |
|||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Budesonide has an average rating of 6.5 out of 10 from a total of 140 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 26% reported a negative effect. |
Entyvio has an average rating of 5.9 out of 10 from a total of 143 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 31% reported a negative effect. |
Zeposia has an average rating of 7.5 out of 10 from a total of 5 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: budesonide side effects in more detail. |
See also: Entyvio side effects in more detail. |
See also: Zeposia side effects in more detail. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all budesonide prices |
View all Entyvio prices |
View all Zeposia prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Entocort EC, Ortikos, Pulmicort Flexhaler, Pulmicort Respules, Tarpeyo, Uceris |
N/A |
N/A |
||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
2.8 hours |
600 hours |
264 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 499 drugs are known to interact with budesonide:
|
A total of 149 drugs are known to interact with Entyvio:
|
A total of 876 drugs are known to interact with Zeposia:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
October 02, 2001 |
May 20, 2014 |
March 25, 2020 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.